Evidence map›Paper›PMID 25593922›Full record

ArticleFrontiers in medicine2014

Gastrointestinal symptoms in morbid obesity.

Mustafa Huseini, G Craig Wood, Jamie Seiler, George Argyropoulos, Brian A Irving, Glenn S Gerhard, Peter Benotti, Christopher Still, David D K Rolston

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03077906 (Study of Gastro-oesophageal Reflux in Patients Having Had Bariatric Surgery), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03077906 completednot on this mapstarted 2017, after this paper: background citation

Study of Gastro-oesophageal Reflux in Patients Having Had Bariatric Surgery

TypeobservationalSponsorPierre WauthyRan2017 to 2017Enrolled400ConditionsGastroesophageal RefluxArmsMedical Files data extraction
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Feeding intolerance in critically ill patients with COVID-19.Clinical nutrition (Edinburgh, Scotland) · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mustafa HuseiniInstitute of Obesity, Geisinger Health System , Danville, PA , USA.
G Craig WoodInstitute of Obesity, Geisinger Health System , Danville, PA , USA.
Jamie SeilerInstitute of Obesity, Geisinger Health System , Danville, PA , USA.
George ArgyropoulosInstitute of Obesity, Geisinger Health System , Danville, PA , USA.
Brian A IrvingInstitute of Obesity, Geisinger Health System , Danville, PA , USA.
Glenn S GerhardInstitute of Obesity, Geisinger Health System , Danville, PA , USA ; Department of Biochemistry, Molecular Biology, Pathology and Laboratory Medicine, Pennsylvania State University , Hershey, PA , USA.
Peter BenottiInstitute of Obesity, Geisinger Health System , Danville, PA , USA.
Christopher StillInstitute of Obesity, Geisinger Health System , Danville, PA , USA.
David D K RolstonInstitute of Obesity, Geisinger Health System , Danville, PA , USA ; Department of Internal Medicine, Geisinger Health System , Danville, PA , USA.
Geisinger Health System · USPennsylvania State University · US

Funding

Genetic Determinants of Weight Loss and Resolution of Co-MorbiditiesR01DK088231 · NIDDK · TEMPLE UNIV OF THE COMMONWEALTH · PI GERHARD, GLENN S · 2011 to 2015
$2.5M
NIDDK NIH HHS R01 DK088231
6 · The paper itself

Abstract

backgroundSeveral reports have shown an increased prevalence of gastrointestinal (GI) symptoms in obese subjects in community-based studies. To better understand the role of the GI tract in obesity, and because there are limited clinic-based studies, we documented the prevalence of upper and lower GI symptoms in morbidly obese individuals in a clinic setting.

objectiveThe aim of our study was to compare the prevalence of GI symptoms in morbidly obese individuals in a weight management clinic with non-obese individuals with similar comorbidities as morbidly obese individuals in an Internal Medicine clinic.

methodsClass II and III obese patients BMI >35 kg/m(2) (N = 114) and 182 non-obese patients (BMI <25 kg/m(2)) completed the GI symptoms survey between August 2011 and April 2012 were included in this study. The survey included 24 items pertaining to upper and lower GI symptoms. The participants rated the frequency of symptoms as absent (never, rarely) or present (occasionally, frequently). The symptoms were clustered into five categories: oral symptoms, dysphagia, gastroesophageal reflux, abdominal pain, and bowel habits. Responses to each symptom cluster were compared between obese group and normal weight groups using logistic regression.

resultsOf the 24 items, 18 had a higher frequency in the obese group (p < 0.005 for each). After adjusting for age and gender, the obese patients were more likely to have upper GI symptoms: any oral symptom (OR = 2.3, p = 0.0013), dysphagia (OR 2.9, p = 0.0006), and any gastroesophageal reflux (OR 3.8, p < 0.0001). Similarly, the obese patients were more likely to have lower GI symptoms: any abdominal pain (OR = 1.7, p = 0.042) and altered bowel habits (OR = 2.8, p < 0.0001).

conclusionThese observations suggest a statistically significant increase in frequency of both upper and lower GI symptoms in morbidly obese patients when compared to non-obese subjects.

Indexed as

body mass indexclinic-based studiesgastrointestinalobesitysymptoms

Identifiers

PMID25593922
PMCPMC4292065
OpenAlexW2036138090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.